Nevro News

Will These 5 Medical Device Stocks Beat This Earnings Season?

Yahoo FinanceMay 6 11:12 ET

Nevro Corp Announces Chief Accounting Officer Resignation

TipRanksApr 25 17:22 ET

Nevro to Report First-Quarter 2024 Financial Results and Host Earnings Conference Call on May 7, 2024

Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain, today...

PR NewswireApr 17 08:30 ET

RBC Capital Sticks to Their Hold Rating for Nevro Corp (NVRO)

TipRanksApr 17 03:59 ET

Nevro Is Maintained at Sector Perform by RBC Capital

Nevro Is Maintained at Sector Perform by RBC Capital

Dow JonesApr 15 14:31 ET

RBC Capital Maintains Sector Perform on Nevro, Lowers Price Target to $16

RBC Capital analyst Shagun Singh maintains Nevro (NYSE:NVRO) with a Sector Perform and lowers the price target from $18 to $16.

BenzingaApr 15 14:21 ET

Express News | Nevro Corp : RBC Cuts Target Price to $16 From $18

Moomoo 24/7Apr 15 02:37 ET

Nevro Is Maintained at Neutral by Mizuho

Nevro Is Maintained at Neutral by Mizuho

Dow JonesApr 11 07:48 ET

Express News | Nevro Corp : Mizuho Cuts Target Price to $16 From $20

Moomoo 24/7Apr 11 07:37 ET

Nevro Is Maintained at Equal-Weight by Wells Fargo

Nevro Is Maintained at Equal-Weight by Wells Fargo

Dow JonesApr 8 08:47 ET

Express News | Wells Fargo Maintains Equal-Weight on Nevro, Lowers Price Target to $14

Moomoo 24/7Apr 8 08:37 ET

Nevro (NYSE:NVRO) Has Debt But No Earnings; Should You Worry?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says 'The biggest investment risk is not the volatility of prices, but whether you will

Simply Wall StApr 4 06:48 ET

Where Nevro Stands With Analysts

Analysts' ratings for Nevro (NYSE:NVRO) over the last quarter vary from bullish to bearish, as provided by 4 analysts.The table below offers a condensed view of their recent ratings, showcasing the ch

BenzingaApr 3 13:01 ET

Nevro Is Maintained at Neutral by Citigroup

Nevro Is Maintained at Neutral by Citigroup

Dow JonesApr 3 12:07 ET

Express News | Citigroup Maintains Neutral on Nevro, Lowers Price Target to $16

Moomoo 24/7Apr 3 11:56 ET

Abbott (ABT) Expands in Canada With First Eterna SCS Use

Yahoo FinanceMar 25 09:15 ET

Here's Why You Should Retain Nevro (NVRO) Stock for Now

Yahoo FinanceMar 21 12:35 ET

FDA Clears Sacroiliac Joint Fusion Device From Nevro

MassDeviceFeb 28 16:49 ET

Nevro1 Gains FDA Clearance for SI Joint Fusion

InvestingFeb 28 16:30 ET

Nevro Receives FDA 510(k) Clearance to Use SI Fixation System Without Need to Include Lateral Screw

Nevro1 Proven to Immediately Transfix Sacroiliac (SI) Joint to Allow for Long-term SI Joint Fusion REDWOOD CITY, Calif., Feb. 28, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical devic

PR NewswireFeb 28 16:10 ET